FDA Approved: APONVIE — Supplemental Application (Heron Therapeutics, Inc.)

View source ↗

Summary

FDA approved a supplemental application for APONVIE (aprepitant) from Heron Therapeutics, Inc., expanding its regulatory authorization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• APONVIE (APREPITANT)

Snippet

SUPPL AP for APONVIE (APREPITANT)